“PET/CT Variants and Pitfalls in Lung Cancer and Mesothelioma”
Authors:
Open Access
- 1 September 2021
- journal article
- review article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 51 (5) , 458-473
Abstract
No abstract availableKeywords
Funding Information
- Ministero della Salute
- Associazione Italiana per la Ricerca sul Cancro
This publication has 75 references indexed in Scilit:
- Malignant Pleural Mesothelioma: Role of CT, MRI, and PET/CT in Staging Evaluation and Treatment ConsiderationsSeminars in Roentgenology, 2013
- Clinical utility of 18-fluorodeoxyglucose positron emission tomography/computed tomography in malignant pleural mesotheliomaExperimental and Therapeutic Medicine, 2012
- Negative Predictive Value of Positron Emission Tomography and Computed Tomography for Stage T1-2N0 Non–Small-Cell Lung Cancer: A Meta-AnalysisClinical Lung Cancer, 2012
- Quantitative Analysis of Response to Treatment with Erlotinib in Advanced Non–Small Cell Lung Cancer Using 18F-FDG and 3′-Deoxy-3′-18F-Fluorothymidine PETJournal of Nuclear Medicine, 2011
- Positron Emission Tomography-Computed Tomography Compared with Invasive Mediastinal Staging in Non-small Cell Lung Cancer: Results of Mediastinal Staging in the Early Lung Positron Emission Tomography TrialJournal of Thoracic Oncology, 2011
- A Novel Prognostic Model for Malignant Mesothelioma Incorporating Quantitative FDG-PET Imaging with Clinical ParametersClinical Cancer Research, 2010
- Clinical Value of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Differentiation of Malignant Mesothelioma from Asbestos-Related Benign Pleural Disease: An Observational Pilot StudyJournal of Thoracic Oncology, 2009
- The Role of Positron Emission Tomography/Computed Tomography in the Diagnosis of Pleural DiseasesThe Thoracic and Cardiovascular Surgeon, 2009
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid TumorsJournal of Nuclear Medicine, 2009
- Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendationsEuropean Journal of Cancer, 1999